Table 1.
Baseline characteristics of participants
| Characteristics | Total Sample (N = 548) |
|
|---|---|---|
| Age | Mean (SD) | 54.3 (10.5) |
| Range | 22–80 | |
| Gender | Female | 548 |
| Race | White | 91.2% |
| Black/African American | 7.8% | |
| Asian | 0.5% | |
| American Indian/Native Alaskan | 0.4% | |
| Ethnicity | Non-Hispanic/Latino | 97.4% |
| Hispanic/Latino | 2% | |
| Unknown | 0.5% | |
| Marital Status | Married | 66.1% |
| Divorced/widowed/separated | 21.8% | |
| Single | 12.2% | |
| Education | High School or less | 36.8% |
| Some college | 33.4% | |
| Bachelor’s degree | 21.2% | |
| Graduate degree | 8.8% | |
| Previous Treatments | Previous Surgery | 84.5% |
| Previous Chemotherapy | 0.9% | |
| Previous Radiation Therapy | 1.3% | |
| Other | 0.7% | |
| Anthracycline | Yes - Doxorubicin | 91.2% |
| Yes - Epirubicin | 1.8% | |
| No - Carboplatin | 6.8% | |
| No - Oxaliplatin | 0.2% | |
| Clinically relevant CRFa | Moderate-severe level (score ≥4) | 52.9% |
| Fatigue severity level (score ≥1)a | Mean (SD) | 4.09 (2.90) |
| Pre-treatment CRFb | Mean (SD) | 2.33 (2.06) |
NOTE: Data might not add to 100% because of rounding.
Abbreviations: SD, standard deviation; CRF, cancer-related fatigue.
a
By single-item “fatigue at its worst” from the Brief Fatigue Inventory.
b
By global Brief Fatigue Inventory score.